Sanofi’s next-gen he­mo­phil­ia drugs take a PhI­II bow — but can they still make their mark at this stage?

3 years ago
R&D

Bis­pe­cif­ic M&A reach­es As­traZeneca; Count­down for Mer­ck­'s big bid; Biotech buy­out in sav­age times; and more

3 years ago
Weekly

FDA says it won't al­low state-li­censed phar­ma­cists to pre­scribe Mer­ck­'s Lagevrio

3 years ago
Pharma
Coronavirus

Hori­zon nabs FDA ex­pand­ed la­bel for gout med Krys­texxa

3 years ago
Pharma
Marketing

Sinopharm mulls $1B buy­out of Chi­na-based DNA syn­the­sis com­pa­ny — re­port

3 years ago
Deals
China

An­oth­er In­di­an drug man­u­fac­tur­er hit with a Form 483 over re­cent ob­ser­va­tions

3 years ago
Pharma
FDA+

Ger­man chem­i­cals com­pa­ny to ex­pand its reach in­to mR­NA in­gre­di­ent pro­duc­tion

3 years ago
Pharma
Manufacturing

Cer­tain dis­card­ed drugs will soon cost phar­ma com­pa­nies

3 years ago
Pharma

Trio of biotechs raise funds to make en­zymes and de­vel­op drugs for IBS and oth­er au­toim­mune dis­eases

3 years ago
News Briefing

Ko­re­an di­ag­nos­tics biotech goes transpa­cif­ic, agree­ing to shell out $1.5B to take Merid­i­an pri­vate

3 years ago
Deals
Diagnostics

Ather­sys’ woes con­tin­ue as As­pire Cap­i­tal ax­es its re­la­tion­ship with the biotech

3 years ago
Financing
Pharma

De­spite plen­ty of bears and lit­tle in­vestor ap­petite, three biotechs beef up 2022's pri­vate place­ment lows

3 years ago
Financing

A por­trait of a biotech buy­out deal in sav­age times: turn­ing a $15.50 of­fer in­to a $7.12 deal

3 years ago
Deals
Bioregnum

Com­pas­sion­ate Use/Ex­pand­ed Ac­cess pro­grams: Three steps to im­prove their im­ple­men­ta­tion for the ben­e­fit of all

3 years ago
Biotech Voices

A year af­ter with­draw­ing IPO, Dy­nacure scraps lead drug for rare mus­cle dis­eases

3 years ago
R&D

En­tos lures for­mer Plexxikon CEO to guide push to­ward the clin­ic; Ex-Bris­tol My­ers im­munol­o­gy chief finds new home

3 years ago
Peer Review

Ab­b­Vie dumps an ear­ly-stage drug in $225M Alzheimer's al­liance with Alec­tor

3 years ago
Deals

Ameet Mallik wraps a $435M com­mer­cial deal short­ly af­ter tak­ing helm at ADC

3 years ago
Deals

No­vo Nordisk work­ers in Ko­rea protest af­ter break­down in salary and perks ne­go­ti­a­tions — re­port

3 years ago
People
Pharma

Africa strikes deal with Pfiz­er for Covid-19 an­tivi­ral — re­port

3 years ago
Pharma
Coronavirus

Vi­iV boosts HIV pre­ven­tion mes­sag­ing with cam­paigns, celebri­ty spokes­peo­ple and frank con­ver­sa­tions

3 years ago
Pharma
Marketing

US gov­ern­ment warns health and phar­ma com­pa­nies af­ter se­ries of ran­somware at­tacks

3 years ago
Pharma

Phar­ma­cists 'ready to get to work' af­ter new FDA au­tho­riza­tion al­lows them to pre­scribe Pfiz­er's Covid-19 an­tivi­ral

3 years ago
Pharma
Coronavirus

Man­u­fac­tur­ing roundup: WuXi con­tin­ues its ex­pan­sion dri­ve with an­oth­er plant open­ing in Changzhou; Swiss biotech nets ...

3 years ago
Manufacturing
First page Previous page 500501502503504505506 Next page Last page
A service from the Financial Times